Pictet Asset Management (Switzerland)’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-3,407
Closed -$216K 1743
2021
Q3
$216K Buy
+3,407
New +$259K ﹤0.01% 1576

Other funds holding CDNA

Pictet Asset Management (Switzerland)'s CDNA Position: Q4 2021 in Review

Pictet Asset Management (Switzerland) sold out of CareDx (CDNA) in Q4 2021, closing a stake of 3,407 shares — an estimated $216K sold.

Pictet Asset Management (Switzerland) first reported a position in CDNA in Q3 2021 and held it in 1 quarter. The position peaked at $216K in Q3 2021. 224 funds tracked by Wall St. Rank hold CDNA as of Q4 2021.

  • Pictet Asset Management (Switzerland) reported no remaining CareDx position as of Q4 2021 after selling out during the quarter.
  • Pictet Asset Management (Switzerland) sold 3,407 CareDx shares in Q4 2021, an estimated $216K.
  • Pictet Asset Management (Switzerland) first reported a position in CareDx in Q3 2021 and held it in 1 quarter.
  • Pictet Asset Management (Switzerland)'s CareDx position peaked at $216K in Q3 2021.
  • 224 funds tracked by Wall St. Rank held CareDx as of Q4 2021.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q4 2021, filed 10 Feb 2022.